APA

Zhou J., Zhou M., Yang F., Liu C., Pan R., Chang Q., Liu X. & Liao Y. (20160104). Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions. : Molecular pharmaceutics.

Chicago

Zhou Jing, Zhou Man, Yang Fei-Fei, Liu Chun-Yu, Pan Rui-Le, Chang Qi, Liu Xin-Min and Liao Yong-Hong. 20160104. Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions. : Molecular pharmaceutics.

Harvard

Zhou J., Zhou M., Yang F., Liu C., Pan R., Chang Q., Liu X. and Liao Y. (20160104). Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions. : Molecular pharmaceutics.

MLA

Zhou Jing, Zhou Man, Yang Fei-Fei, Liu Chun-Yu, Pan Rui-Le, Chang Qi, Liu Xin-Min and Liao Yong-Hong. Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions. : Molecular pharmaceutics. 20160104.